C12N 2760/20022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/20022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 43 US grants and 55 published applications in this corpus.
Search patents in C12N- Granted patents
- 43
- Published applications
- 55
- Assignees
- 47
- Inventors
- 124
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 5 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 3 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 3 | 2 |
| 2020 | 3 | 1 |
| 2021 | 0 | 5 |
| 2022 | 2 | 2 |
| 2023 | 1 | 4 |
| 2024 | 1 | 7 |
| 2025 | 2 | 8 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant plasma membrane-based vesicle, for treating cancer13 May 2025US 12,295,978 B2Shiftbio
- Mutated polypeptides, compositions comprising the same, and uses thereof18 Mar 2025US 12,252,512 B2Interius Biotherapeutics, Inc.
- Polypeptides useful for detecting anti-rhabdovirus antibodies2 Jan 2024US 11,858,962 B2
- Compositions and methods for glioblastoma treatment23 May 2023US 11,654,192 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Compositions and administration of chimeric glycoprotein lyssavirus vaccines for coverage against rabies1 Nov 2022US 11,484,586 B2Icahn School of Medicine at Mount Sinai
- Dissociable envelope binding proteins and uses thereof30 Jul 2026US 2026/0217786 A1CSL Behring GmbH
- Fusion comprising anti-tau antibody and peptide and use thereof16 Jul 2026US 2026/0201024 A1Adel Inc.
- Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof9 Apr 2026US 2026/0098062 A1Sana Biotechnology, Inc.
- Modified rhabdovirus glycoproteins and uses thereof6 Nov 2025US 2025/0339384 A1Regeneron Pharmaceuticals, Inc.
- Methods and compositions of virus-like particles of cytoplasmic type citrus leprosis virus for nanotechnology applications2 Oct 2025US 2025/0304922 A1The Regents of the University of California
Most cited
By later US patents
- DNA-based vaccination of fish162US 5,780,448 AOttawa Civic Hospital Loeb Research · 1998
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Genetically engineered vaccine strain89US 5,364,773 AVirogenetics Corporation · 1994
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001
- Recombinant poxvirus compositions and methods of inducing immune responses55US 5,942,235 AHealth Research, Inc. · 1999